全球房颤导管消融后食管瘘发生率、管理与预后调查:POTTER-AF研究
症状中位出现时间18天,诊断中位时间21天,总死亡率65.8%,保守治疗死亡率89.5%显著高于手术或内镜治疗。
要点
- 房颤导管消融后食管瘘罕见但致命,射频消融发生率显著高于冷冻球囊。
- 发热最常见首发症状,胸部CT诊断率80.2%,症状至诊断中位仅3天。
- 保守治疗死亡率89.5%,手术或内镜干预可显著降低死亡风险。
核心结论
- 房颤导管消融后食管瘘罕见,多与射频能量相关而非冷冻能量。
- 未行手术或内镜干预者死亡率极高。
研究设计与样本
- 共138例患者诊断为食管瘘,其中118例有围术期数据。
主要发现
- 食管瘘总发生率0.025%,射频消融0.038%,冷冻球囊0.0015%(P<0.0001)。
- 症状中位出现时间18天,诊断中位时间21天,症状至诊断中位3天。
- 最常见首发症状为发热(59.3%),胸部CT诊断占80.2%。
- 总体死亡率65.8%,手术、内镜和保守治疗死亡率分别为51.9%、56.5%和89.5%。
临床怎么用
- 房颤导管消融后需警惕迟发发热等食管瘘症状,尽早行胸部CT明确诊断。
- 确诊食管瘘后应积极考虑手术或内镜干预,避免仅保守治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Oesophageal fistula represents a rare but dreadful complication of atrial fibrillation catheter ablation. Data on its incidence, management, and outcome are sparse. METHODS AND RESULTS: This international multicentre registry investigates the characteristics of oesophageal fistulae after treatment of atrial fibrillation by catheter ablation. A total of 553 729 catheter ablation procedures (radiofrequency: 62.9%, cryoballoon: 36.2%, other modalities: 0.9%) were performed, at 214 centres in 35 countries. In 78 centres 138 patients [0.025%, radiofrequency: 0.038%, cryoballoon: 0.0015% (P < 0.0001)] were diagnosed with an oesophageal fistula. Peri-procedural data were available for 118 patients (85.5%). Following catheter ablation, the median time to symptoms and the median time to diagnosis were 18 (7.75, 25; range: 0-60) days and 21 (15, 29.5; range: 2-63) days, respectively. The median time from symptom onset to oesophageal fistula diagnosis was 3 (1, 9; range: 0-42) days. The most common initial symptom was fever (59.3%). The diagnosis was established by chest computed tomography in 80.2% of patients. Oesophageal surgery was performed in 47.4% and direct endoscopic treatment in 19.8% and conservative treatment in 32.8% of patients. The overall mortality was 65.8%. Mortality following surgical (51.9%) or endoscopic treatment (56.5%) was significantly lower as compared to conservative management (89.5%) [odds ratio 7.463 (2.414, 23.072) P < 0.001]. CONCLUSION: Oesophageal fistula after catheter ablation of atrial fibrillation is rare and occurs mostly with the use of radiofrequency energy rather than cryoenergy. Mortality without surgical or endoscopic intervention is exceedingly high.
引用
- Tilz RR, Schmidt V, Pürerfellner H, et al. A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study. Eur Heart J. 2023. PMID: 37062040. doi:10.1093/eurheartj/ehad250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。